Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$24.69

+0.21 (+0.86%)

As of Sep 20, 10:17 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target -8.0% upside

Low Target $15.64

Average Target $22.71

High Target $35.67

Current Price $24.69

Current
$24.69

Target
$22.71

$15.64 $22.71 avg $35.67

Scenario Analysis

Bear Case

$15.64

-36.7%

Low target

Base Case

$22.71

-8.0%

Avg target

Bull Case

$35.67

+44.5%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$27.66

-10.7% from high

52-Week Low

$18.80

+31.3% from low

Target vs 52W High

$22.71

-17.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+20.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.1%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.1%